School of Public Health, Xi'an Medical College, Xi'an 710021, China.
Department of Epidemiology and Health Statistics, School of Public Health, Health Science Center, Xi'an Jiaotong University, Xi'an 710061, China.
Nutrients. 2024 Sep 16;16(18):3122. doi: 10.3390/nu16183122.
It is well-established that prenatal folic acid supplements can reduce neural tube defects. However, the associations between folic acid supplementation, dietary folate intake, and overall folate intake with sex-specific birth outcomes are not yet fully understood.
This study aims to investigate the association of periconceptional folic acid supplement, dietary folate, and total folate intake with the sex ratio at birth and sex-specific birth weight.
Data were sourced from a cross-sectional survey conducted between August and December 2013 in Northwest China, involving 7318 infants and their mothers, recruited using a stratified multistage random sampling method. Folic acid supplements (400 μg/d) were ascertained via a retrospective in-person interview. Dietary folate was evaluated using a validated food frequency questionnaire. Birth outcomes, including sex and weight at birth, were obtained from the Medical Certificate of Birth. Generalized linear models were employed to calculate relative risks (RRs) or differences with 95% confidence intervals (CIs).
No association or dose-response relationship was observed between folic acid supplement, dietary folate, and total folate intake during periconception and the likelihood of male births. However, women who took folic acid supplements during pre- and post-conception were associated with an increased male birth weight by 52.8 (8.1 to 97.5) g. Additionally, the total folate intake during periconception was associated with birth weight for males (upper vs. lower tertile: β = 38.8, 95%CI: 5.0 to 72.5 g, -trend = 0.024) and females (upper vs. lower tertile: β = 42.4, 95%CI: 6.7 to 78.1; -trend = 0.022).
Our findings indicate that periconceptional total folate intake does not correlate with sex ratio at birth but was positively linked to infant birth weights, regardless of gender. These findings offer novel insights into potential benefits of total folate intake, beyond the prevention of neural tube defects, for policymakers and public health.
众所周知,产前叶酸补充剂可以降低神经管缺陷的风险。然而,叶酸补充剂、膳食叶酸摄入和总叶酸摄入与出生性别比和性别特异性出生体重之间的关联尚未完全阐明。
本研究旨在调查围孕期叶酸补充剂、膳食叶酸和总叶酸摄入与出生性别比和性别特异性出生体重的关系。
数据来自于 2013 年 8 月至 12 月在中国西北地区进行的一项横断面调查,采用分层多阶段随机抽样方法招募了 7318 名婴儿及其母亲。通过回顾性面对面访谈确定叶酸补充剂(400μg/d)。膳食叶酸通过验证的食物频率问卷进行评估。出生结局,包括出生时的性别和体重,从《出生医学证明》中获得。采用广义线性模型计算相对风险(RR)或 95%置信区间(CI)的差异。
在围孕期,叶酸补充剂、膳食叶酸和总叶酸摄入与男性出生的可能性之间没有关联或剂量反应关系。然而,在受孕前和受孕后服用叶酸补充剂的女性,其男性出生体重增加了 52.8(8.1 至 97.5)克。此外,围孕期总叶酸摄入与男性(上四分位数与下四分位数:β=38.8,95%CI:5.0 至 72.5 克,-趋势=0.024)和女性(上四分位数与下四分位数:β=42.4,95%CI:6.7 至 78.1;-趋势=0.022)的出生体重有关。
我们的研究结果表明,围孕期总叶酸摄入与出生性别比无关,但与婴儿出生体重呈正相关,无论性别如何。这些发现为决策者和公共卫生部门提供了新的见解,即总叶酸摄入可能除了预防神经管缺陷之外,对出生性别比和出生体重还有潜在的益处。